Premium
Involvement of IL‐6 in a Glucan Model of Vascular Injury
Author(s) -
McClintock Shan D,
Barron Adam,
Deogracias Michael P,
Olle Eric W,
Warner Roscoe L,
Opp Mark R,
Paulauskis Joseph,
Johnson Kent J
Publication year - 2006
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.20.4.a650-c
Subject(s) - glucan , chemistry , medicine , biochemistry
The role of interleukin‐6 (IL‐6) in granulomatous vasculitis is not yet fully understood. To investigate its involvement in granulomatosis injury an interleukin‐6 deficient (IL6−/−) mouse model of glucan‐induced pulmonary vasculitis was employed. Briefly, IL‐6−/− mice and C57B/J6 (IL‐6+/+) mice were injected intravenously with a suspension of glucan isolated from the cell wall of bakers yeast. Histologic examination of paraffin embedded sections demonstrated no significant difference in the number of infiltrating leukocytes between the IL‐6+/+ and IL‐6−/− glucan injured mice. Similar numbers of granulomatous formations were noted in both the IL‐6+/+ and IL‐6−/− injured animals, while no granulomas are seen in saline injected control mice. Cells recovered from the bronchioalveolar lavage (BAL) fluid were differentially stained and counted. While there was a significant increase in infiltrating leukocytes recovered from the BAL following glucan‐induced injury, there was no significant difference between the IL‐6−/− and IL‐6+/+ mice. In addition, no difference was demonstrated in total protein content in the BAL fluid between IL‐6−/− and IL‐6+/+ mice. An additional marker of neutrophil activity, myeloperoxidase (MPO) activity in IL6−/− mice demonstrated significantly less (p<0.005) MPO activity than their IL‐6+/+ counterparts. These studies suggest that IL‐6, while possibly influencing the role that neutrophils play in glucan‐induced vasculitis, does not exacerbate or attenuate the overall T cell mediated pulmonary injury. Work supported by NIH RO1 HL07097